Navigation Links
Antiviral Drugs May Be Useful For Easing Shingles Pain

According to a new study, oral and intravenous antiviral drug may be helpful in easing out shingles-related nerve pain//.

Shingles, which is caused by varicella-zoster virus, is a painful nervous disorder.

Foodconsumer.org reports that researchers at the University of Colorado and Health Sciences Center in Denver gave antiviral treatment to 12 men and three women with moderate to severe pain following shingles. The patients received 10 milligrams of the drug acyclovir intravenously every eight hours for 14 days. They then took three 1,000-milligram pills of the drug valacyclovir per day for one month.

The patients rated their pain on a scale of zero to 10 before they began treatment, then again after completing each therapy, and again one month after completing treatment.

As reported online this week by the journal Archives of Neurology, one month after treatment, eight (53 percent) of the patients reported significant reduction (two or more points) in their pain -- similar to the number of patients who reported similar improvements after day 15 and after day 45.

Five of the patients dropped out of the study early, three of them due to complications caused by the therapy. Most patients tolerated the treatment well, however, the researchers said.

'Although our study was small and without placebo control, the findings suggest a promising effect of antiviral treatment on postherpetic neuralgia [shingles nerve pain],' the study authors concluded.
'"/>




Page: 1

Related medicine news :

1. Roche Commits More Antiviral Pills To Asia For Bird Flu
2. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
3. Antiviral Coating On Bank Notes, Photocopiers Could Help Check Epidemics
4. Antiviral Drugs Curb Influenza Virus
5. Call For Bird Flu Antiviral Drugs To Be Shared
6. New Ribosome Finding Could Lead to Antiviral Therapies
7. Lean Protein Could Be Key to Obesity Drugs
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. Nasal Spray Could Take Drugs Direct to Brain.
10. Emphasis to ban Drugs ads by Doctors
11. Osteoporosis Drugs: right time to take-off
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, ... residential and commercial clients in the northern Alabama and Georgia regions, is embarking ... Since 1977, Nobis Works has built a network of support and education facilities ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending Envision’s ... unique opportunity to get hands-on experience in an emergency medical simulation, When Care ... to gain invaluable, real-life medical skills that are critical success in a future ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
(Date:12/7/2016)... PHILADELPHIA, PA (PRWEB) , ... December 07, 2016 ... ... story of a women growing up with a schizophrenic mother in a unique, ... social worker who specializes in treating trauma and addictive disorders at her private ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... YORK , December 8, 2016 ... focused on the research, distribution, and marketing of pharmaceutical ... affected by patent protection and expiration. Additionally, these firms ... Healthcare sector as a whole. Up for review this ... ), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), ...
(Date:12/8/2016)... DES MOINES, Iowa , Dec. 8, 2016 ... STLT), a pharmaceutical company advancing technologies designed to ... the appointment of Chitra Edwin , Ph.D., ... and Compliance. Dr. Edwin will provide leadership for ... planning for regulatory approvals, preparation of regulatory submissions, ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial ... 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar ... Japan , Kenya , ... , China , Slovakia , ... & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: